Age is an issue of mind over matter — h/t Mark Twain — but early ALS clinical trial results from Google-backed aging-disease ...
Fosigotifator is under clinical development by Calico Life Sciences and currently in Phase II for Unspecified Central Nervous System Disorders.
Google’s ( GOOGL) anti-aging company Calico released disappointing trial results of its first ever drug.
Calico, Google's anti-aging subsidiary, has announced disappointing results from its first-ever drug trial. The experimental ...
The company said Monday that fosigotifator failed to outperform placebo in slowing the neurodegenerative disease, but is ...
AbbVie, Calico and Denali Therapeutics’ hopes of treating amyotrophic lateral sclerosis (ALS) by targeting eIF2B have all ...
A clinical trial evaluating the drug fosigotifator in patients with amyotrophic lateral sclerosis has failed to meet its primary endpoint, according to topline results from the Healey ALS platform ...
In studies by Massachusetts General Hospital, the AbbVie-Calico collaborative drug and Denali Therapeutics' own drug failed to meet endpoints for treating amyotrophic lateral sclerosis, more widely ...
Medpage Today on MSN4d
Herpes and Alzheimer's Tau; Dementia and Autism; Extended Paxlovid for Long COVIDA study of human brain organoids suggested a complex relationship between herpes simplex virus 1 infection and tau, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback